ReviewJournal of Alzheimer's disease : JAD2018

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

Milan Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.